BuzzFeed, Inc. filed a Form 8-K on March 12, 2026, announcing its financial results for the fourth quarter and full year ended December 31, 2025. The company reported total revenues of $185.3 million for the full year 2025, a 2.4% decrease from 2024. Advertising revenue declined by 2.8%, while programmatic advertising ...

CACI International Inc. has issued $500 million in unsecured Senior Notes due 2033, as part of the same series as previously issued notes. The offering, which raised approximately $518 million in net proceeds, was made through a private placement to qualified institutional buyers. CACI intends to use these proceeds to ...

Calavo Growers, Inc. reported its first fiscal quarter 2026 financial results, with total net sales of $122.2 million, a decrease from $154.4 million in the prior year period. Gross profit was $15.2 million, down from $15.7 million. The company reported a net income of $0.7 million ($0.04 per diluted share), compared t...

Callan JMB Inc. has amended its Common Stock Purchase Agreement with Hexstone Capital, LLC. Key modifications include extending the maturity date to April 1, 2027, and revising the Regular Purchase Price to 95% of the lowest daily trading price (or 75% if trading is suspended/delisted). The Regular Purchase Measurement...

Capricor Therapeutics announced its financial results for the fourth quarter and full year ended December 31, 2025. The company's lead product candidate, Deramiocel, for Duchenne muscular dystrophy (DMD) is under U.S. FDA review with a target action date of August 22, 2026. The pivotal HOPE-3 Phase 3 trial met its prim...

CEA Industries Inc. announced the appointment of William B. Miller as Chief Financial Officer, effective March 9, 2026. Mr. Miller brings over 20 years of experience in financial reporting, accounting policy, internal controls, and capital markets, with a background in public company environments. He previously held si...

Champions Oncology, Inc. reported its third quarter fiscal 2026 financial results, ending January 31, 2026. The company achieved a record study service revenue of $16.6 million, a 32% year-over-year increase. However, total revenue slightly decreased to $16.6 million from $17.0 million in the prior-year period, mainly ...

CIMG Inc. filed a Form 8-K to report an amendment to its Articles of Incorporation, effective March 5, 2026. The amendment, filed with the Nevada Secretary of State, increases the authorized shares of the Company's common stock from 600,000,000 to 2,000,000,000, with a par value of $0.00001 per share. This increase was...

CION Investment Corporation reported its financial results for the fourth quarter and year ended December 31, 2025. The company declared base distributions of $0.10 per share for April, May, and June 2026. Key highlights for Q4 2025 include a net investment income of $0.35 per share and a net asset value of $13.76 per ...

Citizens, Inc. reported record total revenues for both the full year and the fourth quarter of 2025. Full year revenues reached $255.6 million, an increase from $245.0 million in 2024. The fourth quarter saw revenues of $72.1 million, up from $63.5 million in the prior year quarter. The company also achieved a record o...

Coastal Financial Corporation announced the appointment of Jeffrey M. Chapman to its Board of Directors, effective March 11, 2026. Mr. Chapman brings over 25 years of experience in financial technology, banking technology, digital transformation, payments, and data-driven platform development. Following his appointment...

On March 12, 2026, Colgate-Palmolive Company announced a change in its Board of Directors. Christopher S. Boerner, Ph.D., CEO and Board Chair of Bristol-Myers Squibb, was elected to the Colgate-Palmolive Board, effective March 15, 2026. Dr. Boerner brings extensive experience in the global biopharmaceutical and healthc...

Constellium SE's Board of Directors has authorized a new share repurchase program of up to $300 million. This program will commence after the 2026 Annual General Meeting of Shareholders on May 21, 2026, and will expire on December 31, 2028. It will replace the existing program initiated in February 2024. The company re...

Cryo-Cell International, Inc. received a notice from NYSE American LLC indicating non-compliance with continued listing standards, specifically a stockholders' deficit and net losses in recent fiscal years. The company's common stock will continue trading under the symbol "CCEL" while it submits a plan of compliance by...

CXApp Inc. received a notice from Nasdaq on March 11, 2026, regarding its failure to meet the minimum bid price requirement of $1.00 per share for its common stock for 30 consecutive business days. The company was initially given until March 10, 2026, to regain compliance but was unable to do so. Nasdaq has now granted...

Cadrenal Therapeutics, Inc. announced on March 12, 2026, that its first-in-class 12-lipoxygenase (12-LOX) inhibitor, CAD-1005, shows potential in targeting inflammatory consequences of obesity and Type 2 diabetes. Pre-clinical research indicates that inhibiting 12-LOX with CAD-1005 may improve glucose homeostasis and r...

California BanCorp announced that its Board of Directors has approved a quarterly cash dividend of $0.10 per share on its common stock. The dividend will be payable on April 15, 2026, to shareholders of record as of the close of business on March 24, 2026. The company also provided a brief overview of its business as a...

Calumet, Inc. announced its intention to offer $150 million in aggregate principal amount of 9.75% Senior Notes due 2031 through its wholly owned subsidiaries. The offering is a tack-on to existing notes issued in January 2026 and will form a single series with the same terms. The net proceeds from this offering are in...

Candel Therapeutics, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2025. The company is advancing its clinical pipeline with plans to initiate a pivotal Phase 3 trial for aglatimagene in non-small cell lung cancer (NSCLC) in Q2 2026 and submit a Biologics License Applicati...

CareCloud, Inc. filed a Form 8-K on March 12, 2026, reporting on two key items. Firstly, the company issued a press release on March 12, 2026, regarding its results of operations and financial condition, with the press release attached as Exhibit 99.1. Secondly, the filing details a change in its board of directors. On...

Century Therapeutics announced its financial results for the fiscal year ending December 31, 2025, highlighting significant progress in its pipeline and a strengthened financial position. The company reported substantial collaboration revenue of $109.2 million, a notable increase from $6.6 million in 2024. Research and...

On March 12, 2026, The Chemours Company completed a private offering of $700 million in aggregate principal amount of 7.875% Senior Notes due 2034. The net proceeds, along with existing cash, were used to redeem $188 million of 5.750% Senior Notes due 2028 for approximately $189.8 million. The remaining proceeds are ea...

Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) filed an 8-K on March 12, 2026, announcing its fourth quarter and full-year 2025 financial results. The company reported net income of $8.2 million ($0.38 per diluted share) for Q4 2025, compared to $7.9 million ($0.39 per diluted share) for Q4 2024. For the ful...

Clene Inc. announced its full year 2025 financial results, reporting a net loss of $26.2 million ($2.65 per share) compared to a net loss of $39.4 million ($5.67 per share) in 2024. Total revenue decreased to $200,000 in 2025 from $342,000 in 2024. Research and development expenses were $14.0 million in 2025, down from...

ConnectM Technology Solutions, Inc. has received an additional $1 million purchase order from Greentech Renewables for Keen high-efficiency heat pumps and smart controls. This brings the total cumulative commitments between the two companies to approximately $3.6 million. This includes a prior $1.7 million order from N...